167 related articles for article (PubMed ID: 33079446)
1. Synthesis, antiproliferative activities, and DNA binding of coumarin-3-formamido derivatives.
Shi J; Lu W; Chen J; Sun L; Yang S; Zhou M; Xu L; Ma Y; Yu L
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000236. PubMed ID: 33079446
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antitumor activity evaluation, and DNA-binding study of coumarin-based agents.
Amin KM; Taha AM; George RF; Mohamed NM; Elsenduny FF
Arch Pharm (Weinheim); 2018 Jan; 351(1):. PubMed ID: 29148081
[TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents.
Lv N; Sun M; Liu C; Li J
Bioorg Med Chem Lett; 2017 Oct; 27(19):4578-4581. PubMed ID: 28888820
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
[TBL] [Abstract][Full Text] [Related]
5. DNA-binding activity and cytotoxic and cell-cycle arrest properties of some new coumarin derivatives: a multispectral and computational investigation.
Khosravifar F; Dehghan G; Bidoki SK; Mahdavi M
Luminescence; 2020 Feb; 35(1):98-106. PubMed ID: 31475787
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of mitochondria-targeted coumarin-3-carboxamide fluorescent derivatives: Inhibiting mitochondrial TrxR2 and cell proliferation on breast cancer cells.
Li Y; Tang Q; Xie Y; He D; Yang K; Zheng L
Bioorg Med Chem Lett; 2021 Feb; 33():127750. PubMed ID: 33340662
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and In Vitro Evaluation of Novel 3, 7-Disubstituted Coumarin Derivatives as Potent Anticancer Agents.
Wang Y; Liu H; Lu P; Mao R; Xue X; Fan C; She J
Chem Biol Drug Des; 2015 Oct; 86(4):637-47. PubMed ID: 25626768
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anticancer activities of some new coumarin derivatives including the triazole ring and their in silico molecular docking studies.
Menteşe E; Güner A; Polatlı E; Emirik M; Bektaş H; Kahveci B
Arch Pharm (Weinheim); 2021 Mar; 354(3):e2000284. PubMed ID: 33146895
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents.
An R; Hou Z; Li JT; Yu HN; Mou YH; Guo C
Molecules; 2018 Sep; 23(9):. PubMed ID: 30200625
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, in vitro antiproliferative activity, and in silico studies of fused tricyclic coumarin sulfonate derivatives.
El-Gamal MI; Oh CH
Eur J Med Chem; 2014 Sep; 84():68-76. PubMed ID: 25016229
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel building blocks of benzosuberone bearing coumarin moieties and their evaluation as potential anticancer agents.
Yadagiri B; Holagunda UD; Bantu R; Nagarapu L; Kumar CG; Pombala S; Sridhar B
Eur J Med Chem; 2014 May; 79():260-5. PubMed ID: 24742385
[TBL] [Abstract][Full Text] [Related]
12. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
Ma CC; Liu ZP
Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
[TBL] [Abstract][Full Text] [Related]
13. Coumarin derivatives with anticancer activities: An update.
Song XF; Fan J; Liu L; Liu XF; Gao F
Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000025. PubMed ID: 32383190
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, and Evaluation of in Vitro and in Vivo Anticancer Activity of 4-Substituted Coumarins: A Novel Class of Potent Tubulin Polymerization Inhibitors.
Cao D; Liu Y; Yan W; Wang C; Bai P; Wang T; Tang M; Wang X; Yang Z; Ma B; Ma L; Lei L; Wang F; Xu B; Zhou Y; Yang T; Chen L
J Med Chem; 2016 Jun; 59(12):5721-39. PubMed ID: 27213819
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, biological activity and multiscale molecular modeling studies of bis-coumarins as selective carbonic anhydrase IX and XII inhibitors with effective cytotoxicity against hepatocellular carcinoma.
Kurt BZ; Dag A; Doğan B; Durdagi S; Angeli A; Nocentini A; Supuran CT; Sonmez F
Bioorg Chem; 2019 Jun; 87():838-850. PubMed ID: 31003041
[TBL] [Abstract][Full Text] [Related]
16. Mito-methyl coumarin, a novel mitochondria-targeted drug with great antitumor potential was synthesized.
Wang H; Xu W
Biochem Biophys Res Commun; 2017 Jul; 489(1):1-7. PubMed ID: 28546001
[TBL] [Abstract][Full Text] [Related]
17. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R
Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941
[TBL] [Abstract][Full Text] [Related]
20. Anticancer Properties of a New Hybrid Analog AD-013 Combining a Coumarin Scaffold with an α-methylene-δ-lactone Motif.
Dlugosz A; Gach-Janczak K; Szymanski J; Deredas D; Krawczyk H; Janecki T; Janecka A
Anticancer Agents Med Chem; 2018; 18(3):450-457. PubMed ID: 28933263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
